Analysts Set Dynex Capital, Inc. (NYSE:DX) Target Price at $13.33

Dynex Capital, Inc. (NYSE:DX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the four brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price target […]

Leave a Reply

Your email address will not be published.

Previous post Royalty Pharma plc (NASDAQ:RPRX) Given Consensus Rating of “Buy” by Analysts
Next post Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Receives $81.42 Consensus PT from Analysts